Known targets — ChEMBL curated mechanism
AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA
The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 3/20 | 0.44 |
| ▸ | CA2 | P00918 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | PDE2A | O00408 | 1/20 | 0.42 |
| ▸ | PDE5A | O76074 | 1/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | APEX1 | P27695 | 1/20 | 0.42 |
| ▸ | PDE4A | P27815 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.42 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.42 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Potassium Ion SCHEMBL2979881 | 1.00 | NT5E (0.47) | NT5EALDH1A1CYP3A4ALOX15TDP1 | |
| Potassium Ion SCHEMBL2979884 | 0.87 | KMT2A (0.47) | ALDH1A1CYP3A4ALOX15TDP1CA1 | |
| Potassium Ion SCHEMBL2983136 | 0.87 | ALDH1A1 (0.57) | NT5EALDH1A1CYP3A4ALOX15TDP1 | |
| Potassium Ion SCHEMBL2965809 | 0.86 | KMT2A (0.58) | NT5EALDH1A1CYP3A4ALOX15TDP1 | |
| SCHEMBL2983082 | 0.85 | ALDH1A1 (0.58) | NT5EALDH1A1CYP3A4ALOX15TDP1 | |
| SCHEMBL7026435 | 0.84 | KMT2A (0.47) | ALDH1A1CYP3A4ALOX15TDP1CA1 | |
| SCHEMBL2973727 | 0.84 | KMT2A (0.59) | NT5EALDH1A1CYP3A4ALOX15TDP1 | |
| SCHEMBL7026429 | 0.84 | ALDH1A1 (0.57) | NT5EALDH1A1CYP3A4ALOX15TDP1 | |
| SCHEMBL2979886 | 0.84 | ALDH1A1 (0.57) | NT5EALDH1A1CYP3A4ALOX15TDP1 | |
| SCHEMBL7026439 | 0.84 | ALDH1A1 (0.57) | NT5EALDH1A1CYP3A4ALOX15TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7781611-B2 | Nitro-sulfobenzamides | AVENTIS CROPSCIENCE GMBH (DE) | 2010-08-24 | — | — | US | disclosed |
| EP-1242386-B1 | NITRO-SULFOBENZAMIDES | BAYER CROPSCIENCE AG (DE) | 2009-08-26 | — | — | EP | disclosed |
| EP-1242386-A1 | NITRO-SULFOBENZAMIDES | Bayer CropScience GmbH (DE) | 2002-09-25 | — | — | EP | disclosed |
| US-20010020092-A1 | Nitro-sulfobenzamides | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2001-09-06 | — | — | US | disclosed |
| WO-2001042226-A1 | NITRO-SULFOBENZAMIDES | AVENTIS CROPSCIENCE GMBH (DE) | 2001-06-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010020092-A1 | Nitro-sulfobenzamides | SULT1A1, SULT2A1, SULT1E1 | NT5E 1835/4885ALDH1A1 605/4885CYP3A4 299/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.